Back

NEWTON-CABG CardioLink-5: Evolocumab and Saphenous Vein Graft Patency

1 September 2025 (13:45 - 13:55)
Organised by: Logo
Congress Presentation Part of: HOT LINE 10 Revascularisation ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Subodh Verma

St. Michael's Hospital, Toronto (Canada)

11 More presentations in this session

Presentation thumbnail
Discussant review - NEWTON-CABG CardioLink-5
Professor F. Mach (Geneva, CH)
Slides
Presentation thumbnail
Panel discussion - NEWTON-CABG CardioLink-5
Presentation thumbnail
TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome
Professor A. Jeppsson (Gothenburg, SE)
Slides
Presentation thumbnail
Discussant review - TACSI
Doctor J. Eikelboom (Hamilton, CA)
Slides
Presentation thumbnail
Panel discussion - TACSI

Access the full session

Session thumbnail
HOT LINE 10
Video

The Event

Event poster

ESC Congress 2025

1 September 2025 13:45 CET
You may be interested in
thumbnail
Congress Presentation
Carotid plaques stabilization and regression with evolocumab
1 September 2025
thumbnail
Congress Presentation
Coronary graft aneurysm as a rare late complication following CABG: a case report
11 December 2025
thumbnail
Congress Presentation
Does the length of evolocumab use contribute to myocardial infarction associated hospital readmissions in patients with ACS?: a single center real world evidence from ELAINE
4 April 2025
thumbnail
Congress Presentation
Indirect comparison of the safety and efficacy of alirocumab and evolocumab: from a comprehensive meta-analysis of 30 randomized controlled trials
3 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources